Moderna to Present at Upcoming Conferences in May/June 2024
Moderna to Present at Upcoming Conferences in May/June 2024
CAMBRIDGE, MA / ACCESSWIRE / May 13, 2024 / Moderna, Inc. (Nasdaq:MRNA), today announced its participation in the following upcoming investor conferences:
马萨诸塞州剑桥/ACCESSWIRE/2024年5月13日/ Moderna, Inc.(纳斯达克股票代码:MRNA)今天宣布参加以下即将举行的投资者会议:
Bernstein's 40th Annual Strategic Decisions Conference (SDC), on Friday, May 31st at 10:00am ET
伯恩斯坦的第40届年度战略决策会议(SDC)将于5月31日星期五举行st 美国东部时间上午 10:00
Jefferies Healthcare Conference, on Thursday, June 6th at 10:00am ET
杰富瑞医疗保健会议,6月6日星期四第四 美国东部时间上午 10:00
Goldman Sachs 45th Annual Global Healthcare Conference, on Monday, June 10th at 1:20pm ET
高盛第45届年度全球医疗保健大会,6月10日星期一第四 美国东部时间下午 1:20
A live webcast of each of these presentations will be available under "Events and Presentations" in the Investors section of the Moderna website at investors.modernatx.com. A replay of each webcast will be archived on Moderna's website for at least 30 days following the presentation.
每场演讲的网络直播将在Moderna网站investors.modernatx.com的 “投资者专区” 的 “活动和演讲” 下提供。每场网络直播的重播将在演讲结束后的至少 30 天内在 Moderna 的网站上存档。
About Moderna
关于 Moderna
Moderna is a leader in the creation of the field of mRNA medicine. Through the advancement of mRNA technology, Moderna is reimagining how medicines are made and transforming how we treat and prevent disease for everyone. By working at the intersection of science, technology and health for more than a decade, the company has developed medicines at unprecedented speed and efficiency, including one of the earliest and most effective COVID-19 vaccines.
Moderna 是创建 mRNA 医学领域的领导者。通过mRNA技术的进步,Moderna正在重新构想药物的制造方式,并改变我们为所有人治疗和预防疾病的方式。通过在科学、技术和健康的交汇处工作了十多年,该公司以前所未有的速度和效率开发了药物,包括最早和最有效的 COVID-19 疫苗之一。
Moderna's mRNA platform has enabled the development of therapeutics and vaccines for infectious diseases, immuno-oncology, rare diseases and autoimmune diseases. With a unique culture and a global team driven by the Moderna values and mindsets to responsibly change the future of human health, Moderna strives to deliver the greatest possible impact to people through mRNA medicines. For more information about Moderna, please visit modernatx.com and connect with us on X (formerly Twitter), Facebook, Instagram, YouTube and LinkedIn.
Moderna 的 mRNA 平台使传染病、免疫肿瘤学、罕见病和自身免疫性疾病的疗法和疫苗的开发成为可能。凭借独特的文化和以 Moderna 价值观和心态为驱动的全球团队,负责任地改变人类健康的未来,Moderna 致力于通过 mRNA 药物为人们带来尽可能大的影响。要了解有关 Moderna 的更多信息,请访问 modernatx.com 并通过 X(前身为 Twitter)、Facebook、Instagram、YouTube 和 LinkedIn 联系我们。
Investors:
Lavina Talukdar
Senior Vice President & Head of Investor Relations
617-209-5834
Lavina.Talukdar@modernatx.com
投资者:
Lavina Talukdar
高级副总裁兼投资者关系主管
617-209-5834
Lavina.Talukdar@modernatx.com
SOURCE: Moderna, Inc.
资料来源:Moderna, Inc.